Copyright © 2013 Knight Sac Media. All rights reserved.http://www.siliconinvestor.com/subject.aspx?subjectid=9020Elan is a bio/pharmaceutical company with roots in Ireland and the US. It has 2 primary foci: biologic and small molecule treatments for neurologic indications and drug delivery. They currently have several sources of revenue: * Drug delivery manufacturing and R&D contract services * Nanotechn...http://www.siliconinvestor.com/images/Logo380x132.pnghttp://www.siliconinvestor.com/subject.aspx?subjectid=902038013210sim1http://www.siliconinvestor.com/readmsg.aspx?msgid=287447312/25/2013 6:14:06 AMQualified Opinionhttp://www.siliconinvestor.com/readmsg.aspx?msgid=287092822/6/2013 8:08:50 AMQualified Opinionhttp://www.siliconinvestor.com/readmsg.aspx?msgid=2856367411/22/2012 12:52:08 PMsteve kammererWhat's left for ELAN? biospace.com  Elan Corporation PLC ( ELN) Will Shutter South S.F. Center as it Shifts R&D to New Company; Job Cuts Ahead 10/1/2012 8:34:55 AM San Francisco Business Times by Ron Leuty, Reporter Elan Corp. will shutter its South San Francisco drug discovery operations as it shifts the wor...http://www.siliconinvestor.com/readmsg.aspx?msgid=2844462710/1/2012 12:49:18 PMSluggerhttp://www.siliconinvestor.com/readmsg.aspx?msgid=281578175/20/2012 12:20:46 PMMark30004-16-2012 chart and setup for ELN here is my chart and setup for this week for ELN: [graphic]http://marklexusblogpage.blogspot.com/2012/04/eln-chart-and-setup-for-next-week.htmlhttp://www.siliconinvestor.com/readmsg.aspx?msgid=280826974/14/2012 10:18:38 PMtom popeWSJ Novartis Gilenya Patient Gets Rare Brain Disease By MARTA FALCONI ZURICH—Novartis AG Friday said a patient treated with its multiple-sclerosis pill Gilenya has been diagnosed with a rare and often fatal brain disease. The Swiss drug maker said the patient, whose identity hasn't been ...http://www.siliconinvestor.com/readmsg.aspx?msgid=280798784/13/2012 11:01:34 AMArthur Radley Good news today: The U.S. Food and Drug Administration allowed marketing of the first test to help determine the risk for a rare brain infection called progressive multifocal leukoencephalopathy, or PML, in people using the drug Tysabri to treat multiple sclerosis or Crohn’s disease. The Stratify JCV Antibody ELISA ...http://www.siliconinvestor.com/readmsg.aspx?msgid=278940721/20/2012 4:05:58 PMBiotech JimFrom this week's Nature issue: Call for Proposals Grants for research on the pathogenesis, diagnosis, risk factors, and treatment of PML are now available from the Progressive Multifocal Leukoencephalopathy Consortium. Letters of intent due January 31, 2012. Please visit www.pmlconsortium.org for more information. ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2779983012/2/2011 7:43:41 AMIRWIN JAMES FRANKELDeciding she should take T was not that hard for me. Getting her to do it was more challenging. We knew the risks. But we also faced the fact that Karen was a Copaxone failure (having become resistant) and had two serious exacerbations in a short time. So she had to change drugs. She could have gone to the ifn's. ...http://www.siliconinvestor.com/readmsg.aspx?msgid=2778528511/24/2011 12:30:42 PMpgo-neilSo glad to hear good news. Improvement is wonderful. I recognize it must have taken real soul searching and courage to step off into the unknown. Really appreciate the updates. All the best for a joyous holiday season for you and your family, graham --http://www.siliconinvestor.com/readmsg.aspx?msgid=2778476611/23/2011 11:58:28 PMRobohogshttp://www.siliconinvestor.com/readmsg.aspx?msgid=2778463511/23/2011 9:41:54 PMIRWIN JAMES FRANKELKaren has now been on T for about 44 months now. Since the post that I am replying to she has had another MRI. Again there were no new plaques, no exacerbations and she continues to do well - better than before starting T. A local paper recently did a story on her. (There are quite a few errors in it, notably missi...http://www.siliconinvestor.com/readmsg.aspx?msgid=2778415411/23/2011 4:20:35 PMsim1Data about Early Use and Long-Term Benefit of TYSABRI Presented at 5th Joint Triennial Congress of ECTRIMS and ACTRIMS --Results of Research Further Supporting PML Risk Stratification Also Presented-- Press Release Source: Elan Corporation, plc On Wednesday October 19, 2011, 2:00 am EDT WESTON, Mass. & DUBLIN--(B...http://www.siliconinvestor.com/readmsg.aspx?msgid=2771135310/19/2011 9:28:21 AMsteve kammererclinicaspace.com  Is this why ELN has been going up as of late? Teva Pharmaceutical Industries Limited ( TEVA)'s Oral Multiple-Sclerosis Drug Fails to Meet Goal of Clinical Trial, Stock Slides 8/1/2011 7:44:48 AM Jerusalem, Israel and Lund, Sweden, August 1, 2011 - Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA...http://www.siliconinvestor.com/readmsg.aspx?msgid=275340068/1/2011 6:55:15 PM